Literature DB >> 17286551

Antiepileptic drug treatment in children.

Stavros M Hadjiloizou1, Blaise F D Bourgeois.   

Abstract

Epilepsy is one of the most common neurological disorders of childhood, and antiepileptic drugs represent the main component of its treatment. The current emphasis in epilepsy treatment is to improve quality of life, not only by suppressing seizure, but also by minimizing the side effects of medications. The last 15 years have been characterized by significant advances in the development of new agents that have helped us to get closer to this goal. Knowledge of the essential properties, key indications and interactions of each antiepileptic drug will help to optimize efficacy and reduce adverse reactions. Age is also a determining factor of the epilepsy phenotype and its treatment. This review addresses the principles of pediatric epilepsy treatment, summarizes the profile of each of the commonly used antiepileptic drugs, and provides a treatment paradigm for particular seizures and epilepsy syndromes of childhood.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286551     DOI: 10.1586/14737175.7.2.179

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  4 in total

1.  Identification and prevention of antiepileptic drug noncompliance: the collaborative use of state-supplied pharmaceutical data.

Authors:  Joseph C Hodges; Janet Treadwell; Amy D Malphrus; Xuan G Tran; Angelo P Giardino
Journal:  ISRN Pediatr       Date:  2014-02-19

Review 2.  The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism.

Authors:  Hueng-Chuen Fan; Herng-Shen Lee; Kai-Ping Chang; Yi-Yen Lee; Hsin-Chuan Lai; Pi-Lien Hung; Hsiu-Fen Lee; Ching-Shiang Chi
Journal:  Int J Mol Sci       Date:  2016-08-01       Impact factor: 5.923

3.  Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.

Authors:  Rik Schoemaker; Janet R Wade; Armel Stockis
Journal:  Eur J Clin Pharmacol       Date:  2017-03-09       Impact factor: 2.953

4.  Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.

Authors:  Rik Schoemaker; Janet R Wade; Armel Stockis
Journal:  Clin Pharmacokinet       Date:  2018-07       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.